Can I read Novel 1-Aminoquinoline TKIs Study on EtoBox?
Novel 1-Aminoquinoline TKIs Study by Şeyma Yıldız is a document available to read on EtoBox.
What is Novel 1-Aminoquinoline TKIs Study about?
This study investigates new 1-aminoquinoline-2(1H)-one derivatives as potential tyrosine kinase inhibitors (TKIs) using in silico docking simulations. The research identifies several derivatives with strong binding affinities and key interactions with the Abelson tyrosine kinase (ABL1), which could enhance the design of more effective cancer therapies. The findings highlight the importance of optimizing TKI design to overcome resistance and improve treatment outcomes in oncology.
- Author
- Şeyma Yıldız
- Language
- EN